Abstract
Insulin degludec/insulin aspart (IDegAsp) is a soluble coformulation of long-acting insulin degludec and short-acting insulin aspart. This open-label, Phase 1 study aimed to determine the pharmacodynamic and pharmacokinetic properties of IDegAsp in children (6-11 yr), adolescents (12-17 yr), and adults (18-65 yr) with type 1 diabetes mellitus (T1DM). Thirty-eight subjects received single subcutaneous IDegAsp dosing (0.5 U/kg) immediately before a standardized liquid meal (17.3 g carbohydrates/100 mL; adjusted for body weight) followed by plasma glucose (PG) and pharmacokinetic blood sampling for 36 and 57 h, respectively. There were no apparent differences between age groups in PG lowering effect (AUCPG baseline,0-6 h,meal,SD ), maximum PG excursion (ΔPGmax,meal,SD ), or maximum PG concentration (PGmax,meal,SD ) after the standardized meal. Estimated ratios (ERs) for total exposure (AUCIAsp,0-12 h,SD ) and maximum concentration (Cmax,IAsp,SD ) of IAsp in IDegAsp were children/adults, 1.69 (95% confidence interval, CI: 1.02; 2.80) and 1.66 (95% CI: 1.10; 2.51); adolescents/adults, 1.14 (95% CI: 0.76; 1.69) and 1.16 (95% CI: 0.84; 1.61). ERs for total exposure (AUCIDeg,0-∞,SD ) and maximum concentration (Cmax,IDeg,SD ) of IDeg ...Continue Reading
References
Oct 1, 1989·Diabetes Care·T W Van Haeften
Sep 19, 2003·The New England Journal of Medicine·Gregory L KearnsRalph E Kauffman
Mar 3, 2004·Pediatrics·Jonathan BurdickGeorgeanna J Klingensmith
Apr 28, 2005·Diabetes Care·UNKNOWN Workgroup on Hypoglycemia, American Diabetes Association
Dec 3, 2005·European Journal of Endocrinology·J-W ChenJ S Christiansen
Sep 6, 2007·Endocrine Reviews·S Edwin FinebergAlan S Krasner
Jan 30, 2009·Pediatric Diabetes·Denis Daneman
Jan 28, 2010·Diabetes Care·Mark PeyrotLuther B Travis
Jul 17, 2010·BMC Pediatrics·Katharine BarnardNorman Waugh
Oct 5, 2010·The Journal of Pediatrics·Louise A KellyMichael I Goran
Aug 31, 2012·Diabetes Care·Irl B HirschMelanie Davies
Feb 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Chantal MathieuStephen C Bain
Jan 29, 2014·Pediatric Diabetes·Torben BiesterThomas Danne
Jun 4, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Tim HeiseHanne Haahr
Jun 18, 2014·Diabetes Care·Jane L ChiangUNKNOWN Type 1 Diabetes Sourcebook Authors
Jul 22, 2014·Pediatric Diabetes·Joseph I WolfsdorfRagnar Hanas
Sep 3, 2014·Clinical Pharmacokinetics·Hanne Haahr, Tim Heise
Sep 4, 2014·Pediatric Diabetes·Marian J RewersDavid M Maahs
Sep 4, 2014·Pediatric Diabetes·Thomas DanneRagnar Hanas
Jan 8, 2015·Pharmaceutical Research·Svend HavelundIb Jonassen
Feb 17, 2015·Pediatric Diabetes·Nandu ThalangeThomas Danne
Mar 17, 2015·Diabetes, Obesity & Metabolism·T HeiseH Haahr
Jun 20, 2015·Drugs & Aging·Martina BrunnerHanne Haahr
Citations
Oct 4, 2016·Clinical Pharmacokinetics·Hanne HaahrTim Heise
Feb 7, 2017·Pediatric Diabetes·Maryam FathHanne Haahr
May 17, 2017·Current Opinion in Pediatrics·Maria Loredana Marcovecchio, Francesco Chiarelli
Feb 23, 2019·Expert Opinion on Drug Metabolism & Toxicology·Marc Rendell
Apr 20, 2020·Pediatric Diabetes·Torben BiesterHanne Haahr
Nov 8, 2018·Clinical Pharmacokinetics·Hanne HaahrTim Heise
Nov 16, 2018·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Samie SabetLaura J Chalmers